- Report
- August 2025
- 192 Pages
Global
From €3126EUR$3,545USD£2,722GBP
€3474EUR$3,939USD£3,024GBP
- Report
- August 2025
- 194 Pages
Global
From €3126EUR$3,545USD£2,722GBP
€3474EUR$3,939USD£3,024GBP
- Report
- October 2025
- 195 Pages
Global
From €3126EUR$3,545USD£2,722GBP
€3474EUR$3,939USD£3,024GBP
- Report
- October 2025
- 182 Pages
Global
From €3126EUR$3,545USD£2,722GBP
€3474EUR$3,939USD£3,024GBP
- Report
- September 2025
- 250 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- April 2025
- 175 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- April 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- April 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Report
- March 2025
- 200 Pages
Global
From €3959EUR$4,490USD£3,447GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1102EUR$1,250USD£960GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£960GBP
- Report
- July 2025
- 350 Pages
Global
From €4364EUR$4,949USD£3,800GBP
- Report
- June 2025
- 400 Pages
Global
From €4364EUR$4,949USD£3,800GBP
- Report
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,141GBP
- Report
- June 2025
- 150 Pages
Global
From €2380EUR$2,699USD£2,072GBP

Lansoprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and erosive esophagitis. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Lansoprazole works by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux and other gastrointestinal disorders.
Lansoprazole is available in both over-the-counter and prescription forms. Over-the-counter lansoprazole is used to treat frequent heartburn, while prescription lansoprazole is used to treat more serious gastrointestinal disorders. Lansoprazole is available in a variety of formulations, including tablets, capsules, and oral suspensions.
The lansoprazole market is a competitive one, with many companies offering their own formulations of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, AstraZeneca, Takeda Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more